Andrés Bermúdez

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Bacterial induction of Snail1 contributes to blood-brain barrier disruption

Brandon J. Kim, Bryan Hancock, Andrés Bermúdez et al. · Journal of Clinical Investigation · 2015 · 142 citations · Full text

Bbb Permeability, Immunology, Zebrafish Survival +16

Evidence supporting a role for astrocytes in the regulation of cognitive flexibility and neuronal oscillations through the Ca2+ binding protein S100β

Adam T. Brockett, Gary A. Kane, Patrick K. Monari et al. · PLoS ONE · 2018 · 72 citations · Full text

Brain Function, Brain Development, Synaptic Transmission +23

The Metabolic Syndrome During Atypical Antipsychotic Drug Treatment: Mechanisms and Management

Trino Baptista, Soaira Mendoza, Serge Beaulieu et al. · Metabolic Syndrome and Related Disorders · 2004 · 42 citations